Skip to main content
. 2024 Mar 20;28(7):e18171. doi: 10.1111/jcmm.18171

FIGURE 4.

FIGURE 4

Downregulation of SRC‐1 decreased cell invasion in HCC cells in vivo. (A–C) Knockdown of SRC‐1 decreased lung metas‐tasis of HepG2 cells. The tumour number on the lung surface was counted. (D, E) SRC‐1 lower HCC patients have a better 5‐year survival than SRC‐1 higher HCC patients and MMP‐9 lower HCC patients have a better 5‐year survival than MMP‐9 higher HCC patents in the database KM‐plotter. ****p < 0.0001.